SSA
MYOV

Schonfeld Strategic Advisors’s Myovant Sciences Ltd. MYOV Stock Holding History

Schonfeld Strategic Advisors’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-51,847
Closed -$930K – 3231
2022
Q3 		$930K Buy
+51,847
New +$828K 0.01% 1322
2021
Q4 		– Sell
-9,100
Closed -$205K – 2705
2021
Q3 		$205K Buy
+9,100
New +$200K ﹤0.01% 1751
2020
Q3 		– Sell
-13,100
Closed -$270K – 1757
2020
Q2 		$270K Buy
+13,100
New +$178K 0.01% 1030
2020
Q1 		– Sell
-59,900
Closed -$930K – 1634
2019
Q4 		$930K Buy
59,900
+37,100
+163% +$374K 0.02% 534
2019
Q3 		$119K Buy
+22,800
New +$169K ﹤0.01% 944
2017
Q4 		– Sell
-66,900
Closed -$1.03M – 927
2017
Q3 		$1.03M Sell
66,900
-3,100
-4% -$37.7K 0.09% 261
2017
Q2 		$819K Hold
70,000
– – 0.08% 312
2017
Q1 		$822K Hold
70,000
– – 0.08% 287
2016
Q4 		$871K Buy
+70,000
New +$811K 0.11% 251

Other funds holding MYOV

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Schonfeld Strategic Advisors's MYOV Position: Q4 2022 in Review

Schonfeld Strategic Advisors sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 51,847 shares — an estimated $930K sold.

Schonfeld Strategic Advisors first reported a position in MYOV in Q4 2016 and held it in 9 quarters. The position peaked at $1.03M in Q3 2017. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

  • Schonfeld Strategic Advisors reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 51,847 Myovant Sciences Ltd. shares in Q4 2022, an estimated $930K.
  • Schonfeld Strategic Advisors first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 9 quarters.
  • Schonfeld Strategic Advisors's Myovant Sciences Ltd. position peaked at $1.03M in Q3 2017.
  • 118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.